Yongheng He

Dr. Yongheng He


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2024 in Journal of Ethnopharmacology
Verified
Journal Article
Open access
XTXiaojuan Tang
Xiaojuan Tang
MHMin He
Min He
YRYuan Ren
Yuan Ren
MJMeng Ji
Meng Ji
XYXiaoqi Yan
Xiaoqi Yan
YHYongheng He
Yongheng He
The Traditional Chinese Medicine Formulas (TCMFs) represent a distinctive medical approach to disease treatment and have been utilized in clinical practice for treating intestinal diseases for thousands of years. Recently, TCMFs have received increasing attention due to their advantages of high efficiency, safety, as well as low toxicity, providing promising strategies for preventing colorectal carcinoma (CRC). Nonetheless, the potential mechanism of TCMFs in preventing CRC has not been fully elucidated. The literature from the past three years was reviewed to highlight the therapeutic effects and underlying mechanisms of TCMFs in preventing CRC. The keywords have been searched, including "traditional Chinese medicine formulas," "herb pairs," "Herbal plant-derived nanoparticles," et al. in "PubMed" and "China National Knowledge Infrastructure (CNKI)," and screened published articles related to the treatment of intestinal precancerous lesions. This review primarily examined the effectiveness and mechanisms of TCMFs in treating intestinal precancerous lesions, highlighting their significant potential in preventing CRC. Gegen Qinlian decoction, Shaoyao decoction, Wu Wei Wan, etc., exert substantial therapeutic effects on intestinal precancerous lesions. These therapeutic effects are demonstrated by a reduction in disease activity index scores, suppression of intestinal inflammation, and preservation of body weight and intestinal function, all of which contribute to the effective prevention of CRC. Besides, the classic Chinese herbal pairs and the extracellular vesicle-like nanoparticles of herbaceous plants have demonstrated superior efficacy in the treatment of intestinal precancerous lesions. Mechanistically, protecting the epithelial barrier, regulating gut microbiota as well as related metabolism, modulating macrophage polarization, and maintaining immune balance contribute to the role of TCMFs in CRC prevention. This review demonstrates the great potential and mechanism of TCMFs in CRC prevention and provides a scientific basis for their utilization in CRC prevention.

20 June 2024 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
XTXiaojuan Tang
Xiaojuan Tang
YRYuan Ren
Yuan Ren
WZWen Zeng
Wen Zeng
XFXiaoting Feng
Xiaoting Feng
MHMin He
Min He
YHYongheng He
Yongheng He
Malignant tumors and central nervous system (CNS) disorders are intricately linked to a process known as "aberrant cell cycle re-entry," which plays a critical role in the progression of these diseases. Addressing the dysregulation in cell cycles offers a promising therapeutic approach for cancers and CNS disorders. MicroRNAs (miRNAs) play a crucial role as regulators of gene expression in cell cycle transitions, presenting a promising therapeutic avenue for treating these disorders and their comorbidities. This review consolidates the progress made in the last three years regarding miRNA-based treatments for diseases associated with aberrant cell cycle re-entry. It encompasses exploring fundamental mechanisms and signaling pathways influenced by miRNAs in cancers and CNS disorders, particularly focusing on the therapeutic effects of exosome-derived miRNAs. The review also identifies specific miRNAs implicated in comorbidity of cancers and CNS disorders, discusses the future potential of miRNA reagents in managing cell cycle-related diseases.

1 April 2025 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
XTXiaojuan Tang
Xiaojuan Tang
CMChangju Ma
Changju Ma
YRYuan Ren
Yuan Ren
YLYuan Lv
Yuan Lv
YHYongheng He
Yongheng He
JWJingjing Wu
Jingjing Wu
Background: Nasopharyngeal carcinoma (NPC) is a major global health issue, especially in Southeast Asia. Solamargine (SM), an alkaloid from natural plants, inhibits various cancer cells. This study evaluates SM’s effects on invasion, migration, EMT markers, angiogenesis, and related pathways in the NPC-specific C666-1 cell line. Methods: In vitro assays, including wound healing, Transwell invasion, Western blot, and tube formation, were used to assess SM’s impact on C666-1 NPC and HUVEC cells. SM concentrations were 2 μM and 5 μM, with axitinib (4 μM) as the control. Network pharmacology and GO-KEGG enrichment analyses were conducted to explore SM’s targets and mechanisms in NPC. Results: SM significantly inhibited C666-1 NPC cell invasion and migration by reducing EMT markers Vimentin and Snail. In HUVEC cells, SM decreased viability, invasion, migration, and tube formation, likely through VEGF signaling inactivation, EZH2 inhibition, and miR-203a-3p upregulation. Network pharmacology and GO-KEGG analyses identified key targets and pathways, suggesting SM’s anti-NPC effects through multiple mechanisms. Discussion: SM inhibits NPC cell invasion and migration by regulating EMT, suppressing angiogenesis, and modulating key pathways. These findings highlight SM’s potential as an anti-cancer agent for NPC and provide new insights into its mechanisms. Network pharmacology and GO-KEGG analysis further identify its therapeutic targets, offering valuable directions for future drug development.

22 January 2026 in Molecular Nutrition & Food Research
Verified
Journal Article
Open access
XTXiaojuan Tang
Xiaojuan Tang
YRYuan Ren
Yuan Ren
YLYongmin Li
Yongmin Li
YLYuan Lv
Yuan Lv
LZLiang Zhao
Liang Zhao
YHYongheng He
Yongheng He
Chemotherapy‐induced senescence‐associated tumor microenvironment (S‐TME) facilitates colorectal cancer (CRC) progression. This study elucidates the mechanism by which Tianma granule (TMG), a traditional Chinese medicine formula, remodels the S‐TME and inhibits CRC, specifically investigating the role of the miR‐29a‐5p/P53 axis. Liquid chromatography–tandem mass spectrometry (LC–MS/MS) identified 18 bioactive components in TMG, and network pharmacology highlighted P53 as a core target. Functional assays, including Cell Counting Kit‐8 (CCK‐8), β‐galactosidase staining, flow cytometry, wound‐healing, and Transwell migration tests, were conducted using doxorubicin (DOX)–induced senescent human umbilical vein endothelial cells (HUVECs) and CRC lines. TMG suppressed CRC cell proliferation, motility, and invasiveness while promoting apoptosis. TMG reduced P53/cyclin‐dependent kinase inhibitor 1A (P21) and senescence‐associated secretory phenotype (SASP) factors (IL‐6, IL‐8, CCL20), while upregulating miR‐29a‐5p in senescent HUVECs. miR‐29a‐5p inhibition enhanced senescence and increased P53/P21/SASP, whereas P53 silencing lowered P21 and decreased miR‐29a‐5p, indicating mutual regulation. In azoxymethane/dextran sulfate sodium (AOM/DSS)‐CRC mice, TMG reduced tumor burden and improved survival, accompanied by lower P53/P21 and restored miR‐29a‐5p in tissues. TMG remodels the chemotherapy‐induced S‐TME and suppresses CRC progression by modulating the miR‐29a‐5p/P53 axis, enhancing apoptosis in senescent cells, and counteracting S‐TME‐mediated tumor growth and metastasis. This highlights TMG's therapeutic potential.